# ArchiMed to acquire Natus Medical for $1.2 billion

Med Platform II, a fund managed by ArchiMed SAS, entered into a definitive agreement to acquire Natus Medical Incorporated for approximately $1.2 billion, or $33.50 per share. The transaction was announced on April 17, 2022.

- Type: Acquisition
- Announced: 2022-04-17
- Where: United States
- Value: $1.20B
- Status: announced
- Products: medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ARCHIMED](https://endata.com/companies/34181.md) (acquirer)
- [Natus Medical](https://endata.com/companies/44289.md) (target)

## Sources

- [marketscreener.com](https://www.marketscreener.com/quote/stock/NATUS-MEDICAL-INCORPORATE-62779406/news/Med-Platform-II-a-fund-managed-by-ArchiMed-SAS-has-entered-into-a-definitive-agreement-to-acquire-N-40086738/), 2022-04-17: "Med Platform II, a fund managed by ArchiMed SAS has entered into a definitive agreement to acquire Natus Medical Incorporated from a group of shareholders for approximately $1.2 billion."
- [hearingreview.com](https://hearingreview.com/hearing-products/testing-equipment/testing-diagnostics-equipment/archimed-acquire-natus-medical-inc), 2022-04-19: "The sale of Natus to ArchiMed will provide our shareholders with immediate and substantial cash value."
- [medicalbuyer.co.in](https://medicalbuyer.co.in/archimed-to-acquire-natus-for-1-2b/), 2022-04-22: "ArchiMed’s mix of operational, medical, scientific and financial expertise will help us continue our mission to serve our customers while delivering immediate value to shareholders."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.